# Inhaled Corticosteroids (ICS) on Pulmonary Endothelial Function in COPD

> **NCT05607719** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **University of Miami** · enrollment: 30 (estimated)

## Conditions studied

- Chronic Obstructive Pulmonary Disease

## Interventions

- **DRUG:** Bevespi
- **DRUG:** Bretzri

## Key facts

- **NCT ID:** NCT05607719
- **Lead sponsor:** University of Miami
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-04-11
- **Primary completion:** 2026-06-30
- **Final completion:** 2026-06-30
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-04-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05607719

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05607719, "Inhaled Corticosteroids (ICS) on Pulmonary Endothelial Function in COPD". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05607719. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*